Edit
301 Moved Permanently
http://www.signifikance.com/Last activity: 09.02.2015
Active - Reference to Mercusuar
Due to the plummeting costs, there has been an increase in genomic testing. However, the current way to analyze large output of genomic tests is to do it manually and it can take up to several weeks to find any actionable information. At Signifikance, we have developed a platform that automatically analyzes a patient's genomic data and within minutes, compiles a report with personalized treatment options for the patient's provider.
Location: United States, New York
Investors 1
| Date | Name | Website |
| - | Blueprint ... | blueprinth... |
Mentions in press and media 3
| Date | Title | Description |
| 09.02.2015 | Blueprint Health seventh class tackles diabetes, insurance, genomics | Blueprint Health took to Twitter last week to announce its newest, seventh class of healthcare startups in New York City. Blueprint is a member of TechStars’ Global Accelerator Network, and startups in the Blueprint Health accelerator recei... |
| 06.02.2015 | Blueprint Health’s 7th class of startups includes genetic risk tools, remote monitoring for diabetes | GroupHub came up with a platform to make it easier for insurance brokers to compete in the runup to HIPAA electronic compliance mandates that will be effective in 2016. It helps them validate and submit enrollment applications to insurance ... |
| - | Blueprint Health’s 7th class of startups includes genetic risk tools, remote monitoring for diabetes | A way to help endocrinologists make the most of new reimbursement opportunities, remote monitoring and genetic risk assessment are some of the business ideas behind the latest crop of early stage health IT companies in the New York City-bas... |